Retail & Wholesale » Retail | China NT Pharma Group Co. Ltd.

China NT Pharma Group Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
627
700
419
248
255
143
Total Accounts Receivable
314
384
350
594
841
343
Inventories
170
161
215
226
188
51
Other Current Assets
256
65
9
30
23
135
Total Current Assets
1,367
1,310
994
1,098
1,307
673
Net Property, Plant & Equipment
242
330
359
297
301
331
Total Investments and Advances
20
-
-
60
23
20
Intangible Assets
57
48
159
1,290
1,563
1,450
Other Assets
19
49
52
48
50
66
Total Assets
1,846
1,857
1,669
2,859
3,313
2,540
ST Debt & Current Portion LT Debt
404
680
312
996
796
Accounts Payable
556
594
28
72
158
Income Tax Payable
41
19
22
29
41
Other Current Liabilities
180
119
230
429
454
Total Current Liabilities
1,181
1,412
591
1,526
1,449
Long-Term Debt
397
150
-
-
545
Deferred Taxes
139
119
105
64
68
Other Liabilities
-
-
-
174
-
Total Liabilities
1,579
1,563
591
1,700
1,994
Common Equity (Total)
267
266
1,063
1,146
1,309
Total Shareholders' Equity
267
266
1,063
1,146
1,309
Total Equity
267
266
1,077
1,159
1,319
Liabilities & Shareholders' Equity
1,846
1,857
1,669
2,859
3,313
Accumulated Minority Interest
-
-
15
13
10
Non-Equity Reserves
-
28
-
-
-

About China NT Pharma Group Co.

View Profile
Address
Unit 1505, 15th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.ntpharma.com
Updated 07/08/2019
China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the provision of distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. It operates through the following segments: Proprietary Products Production and Sales, and Miacalcic. The Proprietary Products Production and Sales segment engages in the production and sales of the company branded products and generic drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.